Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...

Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...

Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...

The board of Quest Diagnostics Incorporated ( NYSE ... likely played influential roles in the 11.57% stock price increase over the past quarter. The broader... Aveanna (AVAH) was a big mover ...

Grail shares are trading higher Wednesday after the company announced a new collaboration with Quest Diagnostics aimed at improving provider access to its Galleri multi-cancer early detection test.

Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...

With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX ... it is trading below the mean price target of $178.25. On the date of publication, Sohini Mondal did not have ...

StockNews.com lowered shares of Quest Diagnostics from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. Robert W. Baird set a $189.00 price target on Quest ...

likely played influential roles in the 11.57% stock price increase over the past quarter. The broader... Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced ...

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS ...